At 6:46 on the morning of December 4th, 2024, a man in a grey hoodie walked toward the Hilton hotel on Sixth Avenue in Manhattan. He moved with purpose. He knew exactly where he was going. Minutes later, Brian Thompson — CEO of UnitedHealthcare, the largest health insurance company in America — lay dead on the sidewalk. He never made it to the investor conference inside.
Five days later, a customer at a McDonald's in Altoona, Pennsylvania recognized a face from the news. Police found Luigi Mangione eating breakfast. In his backpack: a ghost gun, a fake ID in the name Mark Rosario, and a spiral-bound notebook filled with handwritten pages that prosecutors now call a manifesto.
The question that will define this case isn't whether those items existed. It's whether a jury will ever be allowed to see them.
The CEO and the Company Under Fire
Brian Thompson was 50 years old. A Minnesota native, he'd spent his career in healthcare before becoming UnitedHealthcare's CEO in 2021. He had a wife and two sons.
The company he led insures more Americans than any other — and has faced years of criticism for it. In 2023, a congressional investigation found UnitedHealthcare denied prior authorization requests at higher rates than its competitors. Stories of coverage denials, claim rejections, and families bankrupted by medical debt became a steady drumbeat in news coverage.
None of this justifies murder. But it explains why Thompson's death became more than a crime story. It became a referendum on a healthcare system that millions of Americans believe has failed them.
The Five-Day Manhunt
Surveillance cameras captured the shooter outside the Hilton — grey hoodie, backpack, a firearm fitted with a suppressor. Within hours, the footage was everywhere. The NYPD traced his movements to a hostel on the Upper West Side, where he'd registered under a fake ID: Mark Rosario.
That name surfaced again on December 9th, when police approached Luigi Mangione at that Altoona McDonald's. When asked for identification, he gave them the same name — Mark Rosario.
Mangione was 26 years old. An Ivy League graduate from a wealthy Baltimore family. Degrees in computer science and engineering from the University of Pennsylvania. His family owned nursing homes in Maryland. By every external measure, he had everything to lose.
Friends later described him as brilliant but troubled. He'd struggled with chronic back pain following a surfing injury and had become increasingly isolated in the months before December.
The Evidence That May Never Reach the Jury
In Mangione's backpack, investigators found a 9mm ghost gun — a firearm assembled from parts, without serial numbers, untraceable. Prosecutors say it matches the weapon used in the shooting.
But the most significant item wasn't the gun. It was the notebook. According to court documents, the handwritten pages expressed hostility toward health insurance companies and included ideas about targeting a CEO at an investor conference. A crumpled to-do list found on Mangione mentioned Best Buy; investigators later found a receipt for a waterproof digital camera and memory cards. What he intended to document remains unclear.
Now defense attorneys are fighting to suppress this evidence — including Mangione's statements to police. The argument centers on Miranda rights: when exactly was he read them, and did he understand them during the confusion of his arrest?
Miranda protections aren't a technicality. They're a constitutional safeguard. When police obtain evidence improperly — without proper warnings, without warrant, without consent — courts may rule it inadmissible. The jury never sees it. Not because the truth should be hidden, but because process matters.
Whether Mangione's statements and the backpack's contents survive these challenges will be decided in pre-trial hearings. The outcome could reshape what the jury is allowed to consider.
A Trial Scheduled, A Nation Watching
In January 2026, a federal judge dismissed the charges that carried the death penalty, citing jurisdictional issues with the firearms statute. Mangione no longer faces execution. But he still faces murder charges in New York State. Life in prison remains on the table.
Jury selection is scheduled to begin October 5th, 2026, with opening statements set for October 26th. Between now and then: months of motions, evidence challenges, and arguments about what twelve jurors will ultimately hear.
The notebook — those handwritten pages — may be the prosecution's most powerful evidence of premeditation. Or it may be the most contested item in the case.
The Tension That Won't Resolve
Something unusual happened in the weeks after the shooting. While most condemned the violence, some expressed sympathy not for the victim, but for the alleged motive. Healthcare claim denials. Coverage refusals. Families losing everything to medical debt. The anger is real, even if the act is inexcusable.
This puts the trial in difficult territory. How do you select a jury that can separate the question of guilt from their own experiences with a healthcare system that has failed them?
Brian Thompson is dead. Luigi Mangione awaits trial. And somewhere in a Pennsylvania evidence room, a notebook holds whatever truth he chose to write down.
The courts will decide what's admissible. The jury will decide what's proven. And the rest of us are left with a case that refuses to be simple — one that sits at the intersection of healthcare, inequality, violence, and what happens when systems fail people. None of those things make murder acceptable. But they're why this case won't fade quietly. Too many Americans see their own frustrations reflected in it.
